Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) represented a move of -5.54 percent or $0.18 per share and closed its previous day trading session at $2.73. 2.9 Million Shares were traded in the last trading session with an Average Volume of 2.58 Million Shares. The stock currently has a Market Capitalization of 465.11 Million.
Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Its goal is to file one new investigative new drug application in a significant indication each year. The Company’s pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel’s productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. We have product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia, and asthma and allergy, as well as in cancer.
The stock traded between $2.56 and $4.71 over 1-Year time period showing its price to sales ratio of 172.26. Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-12.33 and 200-Day Simple Moving Average of $-21.34. Its Price to Free Cash Flow is 0 and Price to Book of 3.59.
Analyst’s recommended the stock as 1.7 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) reported its Actual EPS of $-0.16/share. The analysts offering Earnings Estimates for the company were believing that Rigel Pharmaceuticals, Inc. could bring EPS of $-0.16/share. The difference between Actual EPS and Estimated EPS was 0 Percent. Thus showing an Earnings Surprise of 0 Percent.
Intelsat S.A. (NYSE:I)
In the last trading session, Intelsat S.A. (NYSE:I) added its value by -4.28% closing at the price of $32.89. The stock currently has market capitalization of 4.62 Billion, with average volume of 2.65 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Intelsat S.A. (NYSE:I) is showing beta of 0.93. This particular value of beta suggests that Intelsat S.A. (NYSE:I) has historically moved 93% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Intelsat S.A. (NYSE:I) is at $-2.18.
The stock currently has RSI of 56.31. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Intelsat Investments S.A. provides satellite communications services. The company offers network services comprising transponder services, video distribution and contribution services, hybrid satellite, fiber and teleport managed services to media companies, fixed and wireless telecommunications operators, data networking service providers for enterprise and mobile applications, multinational corporations, internet service providers, military and government sectors. Intelsat Investments S.A. is based in Luxembourg.
Intelsat S.A. (NYSE:I) topped its 52-week high price of $37.70 on 10/17/18 and 52-Week Low Price of $ 2.44 on 02/06/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 5.88% and monthly volatility of 6.99% respectively.